Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Cell type, High grade lymphoma, Hodgkin lymphoma, Leukaemia, Lymphoma, Myeloma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at using a drug called azacitidine for people who have chronic GvHD.
This trial was open for people to join between 2016 and 2019. The team published the results in 2021.
Recruitment start: 3 June 2016
Recruitment end: 31 December 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ram Malladi
Blood Cancer UK
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 2 May 2022
CRUK internal database number: 12132
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
